190 related articles for article (PubMed ID: 25392852)
1. Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia.
Selmeczi A; Roach RE; Móré C; Batta Z; Hársfalvi J; van der Bom JG; Boda Z; Oláh Z
Thromb Haemost; 2015 Feb; 113(2):283-9. PubMed ID: 25392852
[TBL] [Abstract][Full Text] [Related]
2. Thrombin generation post elective caesarean section: effect of low molecular weight heparin.
Ismail SK; Norris L; Muttukrishna S; Higgins JR
Thromb Res; 2012 Nov; 130(5):799-803. PubMed ID: 22365560
[TBL] [Abstract][Full Text] [Related]
3. Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women.
Ismail SK; Norris L; O'Shea S; Higgins JR
Thromb Res; 2014 Aug; 134(2):234-9. PubMed ID: 24984985
[TBL] [Abstract][Full Text] [Related]
4. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
[TBL] [Abstract][Full Text] [Related]
5. Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis.
Simeone R; Giacomello R; Bruno G; Parco S; Maximova N; Martinelli M; Zito G; Luppi S; Cervi G; Ricci G
Acta Haematol; 2017; 137(4):201-206. PubMed ID: 28478442
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.
Chowdary P; Adamidou D; Riddell A; Aghighi S; Griffioen A; Priest P; Moghadam L; Kelaher N; Huq FY; Kadir RA; Tuddenham EG; Gatt A
Br J Haematol; 2015 Mar; 168(5):719-27. PubMed ID: 25351814
[TBL] [Abstract][Full Text] [Related]
7. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
8. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
9. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
10. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
Paskaleva I; Karagiozova Zh; Doncheva E; Dineva D
Akush Ginekol (Sofiia); 2014; 53(2):3-10. PubMed ID: 25098102
[TBL] [Abstract][Full Text] [Related]
12. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
[TBL] [Abstract][Full Text] [Related]
13. ProCGlobal and endogenous thrombin potential during pregnancy.
Hron G; Kyrle PA; Kaider A; Philipp K; Pabinger I; Kollars M; Eichinger S
Am J Obstet Gynecol; 2010 Nov; 203(5):463.e1-6. PubMed ID: 20598285
[TBL] [Abstract][Full Text] [Related]
14. [Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients].
Boda Z; László P; Rejtö L; Tornai I; Pfliegler G; Rák K
Orv Hetil; 1996 Jan; 137(4):183-5. PubMed ID: 8721833
[TBL] [Abstract][Full Text] [Related]
15. Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study.
Abbattista M; Gianniello F; Novembrino C; Clerici M; Artoni A; Bucciarelli P; Capecchi M; Peyvandi F; Martinelli I
Lancet Haematol; 2020 Apr; 7(4):e320-e328. PubMed ID: 32112716
[TBL] [Abstract][Full Text] [Related]
16. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
Bauersachs RM; Dudenhausen J; Faridi A; Fischer T; Fung S; Geisen U; Harenberg J; Herchenhan E; Keller F; Kemkes-Matthes B; Schinzel H; Spannagl M; Thaler CJ;
Thromb Haemost; 2007 Dec; 98(6):1237-45. PubMed ID: 18064320
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin.
Hoke M; Kyrle PA; Philipp K; Pabinger I; Kaider A; Schönauer V; Quehenberger P; Eichinger S
Thromb Haemost; 2004 May; 91(5):935-40. PubMed ID: 15116254
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation assays for optimizing low molecular weight heparin dosing in pregnant women at risk of thrombosis--response to Ismail et al.
Chowdary P; Riddell A; Hamid C; Gatt A
Br J Haematol; 2016 Feb; 172(4):643-4. PubMed ID: 26036455
[No Abstract] [Full Text] [Related]
20. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
